其它抗肿瘤药

其它抗肿瘤药

---

维罗非尼 培美曲塞二钠 保特佐米 奥沙利铂 康普瑞汀磷酸二钠 来那度胺 西地尼布 卡铂 顺铂 米托坦 3,8,13,18-Tetraazaeicosane-6,15-diol, hydrochloride (1:4), (6S,15S)- / 艾鲁妥单抗 戈莱恩尼单抗 利妥昔单抗 化合物 Flezurafenibum 英夫利昔单抗 Butanedioic acid, 1-[(1R,2S)-1-[[[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl]oxy]carbonyl]-2-[[(1,1-dimethylethoxy)carbonyl]amino]-2-phenylethyl] ester 锗螺胺 OGX-011 efineptakin alfa Research Grade Sozinibercept AB521 普马司他 西他土珠 3-[(4-氰基苯基)甲基]-N-(3-甲基-5-异噻唑基)-ALPHA-氧代-1-中氮茚乙酰胺 化合物 T29964 Samarium sm 153 lexidronam pentasodium Hu1D10 (4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺 BRICICLIB SODIUM 8-氯腺苷-3',5'-环状磷酸钠盐 LyMphoCide ALDOXORUBICIN CS-2398 Lisavanbulin TVB2640 LIFIRAFENIB Astuprotimut-R BKT140 化合物 T2584L2 BMS-986205 1822357-78-7 化合物 T4532L MC-VC-PABC-AUR0101 Muparfostat sodium (S)-4-(4'-氯联苯-4-基)-4-氧代-2-(苯硫基甲基)丁酸 维汀-格仑妥木单抗 RAD51-IN-2 FARLETUZUMAB ( 法妥组单抗 ) DROZITUMAB ( 曲齐妥单抗 ) Brontictuzumab Vandortuzumab Vedotin ZANIDATAMAB (泽尼达妥单抗 ) Cofetuzumab AMIVANTAMAB (埃万妥单抗 ) AXATILIMAB (艾克利单抗 ) TINENGOTINIB 卡折来新 莱莫尼利单抗 培利霉素 METHYL 5-AMINO-4-OXOPENTANOATE INTERFERON ALFA-N1 辛曲秦 利沃奇拜单抗 艾瑞西普 化合物 BOCODEPSIN Cobomarsensodium Oberotatug 化合物 Verzistobart Rosomidnar ADOZELESIN Research Grade OnvapegleukinAlfa LEDOXANTRONE 盐酸盐 1H-Isoindole-1,3(2H)-dione, 2-[(3S)-2,6-dioxo-3-piperidinyl]-4-[[[2-fluoro-4-[[3-(4-morpholinyl)-1-azetidinyl]methyl]phenyl]methyl]amino]-, hydrochloride (1:1) N-(Phosphonoacetyl)-L-aspartic acid 1,4-disodium salt Teroxirone Dibenz[cd,g]indazol-6(2H)-one,5-[(3-aminopropyl)amino]-7,10-dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-,hydrochloride (1:2) MGA271 西达本胺 1398568-47-2 1702967-37-0 MOLIBRESIB BESYLATE TAK-981 Lorvotuzumab Mertansine ICRUCUMAB ( 艾芦库单抗 ) Flanvotumab Vorsetuzumab Mafodotin Lenzilumab TAFASITAMAB (ANTI-CD19) Inebilizumab Vadastuximab Depatuxizumab Mafodotin Belantamab CETUXIMAB SAROTALOCAN (沙西妥昔单抗 ) EPCORITAMAB (艾可瑞妥单抗 ) Tavolimab 比生群二盐酸盐 MUTANT IDH1-IN-6 帕武鲁他单抗 莫帕利单抗 TULMIMETOSTAT Etoprine 化合物 Osemitamab 万多妥珠单抗 Visugromab 化合物 DL-01 BECATECARIN Olaptesedpegol 化合物 PATRITUMAB DERUXTECAN 德达博妥单抗 米托洁林 米托司培 (6S,7S)-7-[(羟基氨基)甲酰基]-6-[(4-苯基-1-哌嗪基)甲酰基]-5-氮杂螺[2.5]辛烷-5-甲酸甲酯 司韦芬 Leurosine Sulfate MITOCROMIN Unii-W6E275iurx IPI-926 CS-1107 Cevipabulin fumarate SN2310 PCI-24781 HCL Lu-DOTA-TOC 磷酸氢二钠(³²P) Elpamotide EDICOTINIB 帕比司他乳酸水合物 Cadazolid Lirilumab ALG1001 DS-3201 Iberdomide hydrochloride LUTETIUM LU177-DOTA-TATE PF 3084014 HYDROBROMIDE 二水合氨甲嘌呤 Tucotuzumab Celmoleukin ONARTUZUMAB ( 奥那妥组单抗 ) Tarextumab Lumretuzumab Lilotomab Ascrinvacumab Cetrelimab 奥博妥单抗 TECLISTAMAB (特立妥单抗 ) SERCLUTAMAB (思诺妥单抗 ) PRALUZATAMAB (普罗妥单抗 ) IMG-7289 IMG-7289 ONC-201 DIHYDROCHLORIDE, ONC-201 HCL, ONC201; ONC 201; ONC-201; NSC350625; NSC-350625; NSC 350625; IMIPRIDONE; TIC10; TIC 10; TIC-10 化合物 T24466 SECLIDEMSTAT MESYLATE 埃纳妥单抗 Gold-198 L-Tyrosine, N-acetylglycyl-L-valyl-L-arginyl-L-alanyl-L-lysyl-L-alanylglycyl-L-valyl-L-arginyl-L-asparaginyl-L-norleucyl-L-phenylalanyl-L-lysyl-L-seryl-L-α-glutamyl-L-seryl- 阿考达唑 氯苯氨啶 BA301 BMS-986351, BMS986351, CC-95251, CC95251 N-(2,6-bis(isopropyl)phenyl)-N'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea 化合物 HDM-201 SUCCINATE 枸橼酸沃拉西德尼半水合物 化合物 INUPADENANT HCL L-Argininamide, N2-(4-fluorobenzoyl)-L-arginyl-L-arginyl-3-(2-naphthalenyl)-L-alanyl-L-cysteinyl-L-tyrosyl-N5-(aminocarbonyl)-L-ornithyl-L-lysyl-D-lysyl-L-prolyl-L-tyrosyl-L-arginyl-N5-(aminocarbonyl)-L-ornithyl-L-cysteinyl-, cyclic (4→13)-disulfide, acetate (1:) Immunoglobulin G1, anti-(human B7 homolog 4 protein) (human monoclonal INT-016 γ1-chain), disulfide with human monoclonal INT-016 κ-chain, dimer, reduced, 214′′,214′′′,220,220′,226,226′,229,229′-octakis(thioether) with N-[31-(3-mercapto-2,5-dioxo-3-pyrrolidinyl)-1,29-dioxo-4,7,10,13,16,19,22,25-octaoxa-28-azahentriacont-1-yl]-L-valyl-N-[(9S)-9-ethyl-2,3,9,10,13,15-hexahydro-9-hydroxy-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-4-yl]-L-alaninamide (ACI) 化合物 CARBETIMER 阿地白介素 Tusamitamab 3-Piperidinemethanol, 3-amino-1-[4-[(6-amino-9H-purin-9-yl)methyl]-6-(2,5-difluoro-4-methoxyphenyl)-3-pyridinyl]-α-(difluoromethyl)-, (αS,3R)-, (2S,3S)-2,3-dihydroxybutanedioate (1:1) Kw-2871 替莱妥米单抗 SARIDEGIB HYDROCHLORIDE 甲磺酸艾日布林 化合物 TIGAPOTIDE TRIFLUTATE 5-Pyrimidinecarboxamide, 2-[(1a,5a,6a)-6-[[(6-fluoro-2-quinolinyl)methyl]amino]-3-azabicyclo[3.1.0]hex-3-yl]-N-hydroxy- LXS-196 Adegramotide Samalizumab CC220 Pidilizumab G1T38 戈利昔替尼 化合物 LIFIRAFENIB MALEATE TNF信号通路激活剂多肽FEXAPOTIDE Muparfostat 化合物 T24610 Oportuzumab Monatox ENSITUXIMAB ( 恩妥昔单抗 ) TABALUMAB ( 他贝芦单抗 ) Denintuzumab Mafodotin Vadastuximab Talirine Vonlerolizumab Telisotuzumab Vedotin Flotetuzumab 伏派利单抗 NAXITAMAB (那昔妥单抗 ) MIRZOTAMAB (米佐妥单抗 ) PACMILIMAB (帕克米利单抗 ) RMC-4630 贝伐珠单抗 舒兰德林 化合物 JSH-009 拉格芙利单抗 米帕妥单抗 匹维奇单抗 β-Alanine, N-(aminoiminomethyl)-, butanedioate (2:1) 赛必妥单抗 塞奥罗奈 依沙芦星 化合物NEDOMETINIB 赛帕利单抗 Benzamide, 5-fluoro-2-[[4-[7-[[(1S,3S,4R)-5-methylene-2-azabicyclo[2.2.2]oct-3-yl]carbonyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-N,N-bis(1-methylethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) Efizonerimod alfa L-Valine, S-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenonyl-2-(aminomethyl)-4-thiazolecarbonyl-2-methylalanyl-, (5→2)-lactone, benzenesulfonate (1:1) Tilsotolimod sodium Praluzatamab ravtansine 戈替苏拜单抗 Ozuriftamab vedotin (anti-ROR2) Research Grade Oberotatug Eciskafusp Tagraxofusp Zamzetoclax (compound 1) 司沃妥塔单抗 Antibiotic U-12,241 catumaxomab 得尼考新 Anti-CD40L (SP-4-2)-[(7S,8S,17R,18R)-13-乙酰基-18-乙基-5-(2-甲氧基-2-氧代乙基)-2,8,12,17-四甲基-3-[[(2-磺酰乙基)氨基]甲酰基]-21H,23H-卟吩-7-丙酸(4-)-KN21,KN22,KN23,KN24]钯(2-) (-)-N-[4-(2,2-二甲基丙酰基)-5-[[2-(乙基氨基)乙磺酰胺]甲基]-5-苯基-4,5-二氢-1,3,4-噻二唑-2-基]-2,2-二甲基丙酰胺 AVE8062A Glycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl- 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c][1]benzopyran-3-yl sulfaMate BEXLOSTERIDE. LEE011 纳武单抗 946150-57-8 AMCASERTIB Strontium chloride sr 89 [USAN] (223)RaCl2 1422253-38-0 221139-79-3 (2-hydroxyethyl)trimethylazanium: 3-methyl-1,1- dioxo-2H-l6-,2,4-benzothiadiazin-2-ide SULFO-PDBA-DM4 Cevipabulin succinate // ASN-002_Hydrochloride CC-92480 重组肿瘤坏死因子 阿麦妥单抗 RILOTUMUMAB ( 利妥木单抗 ) UBLITUXIMAB ( 乌妥昔单抗 ) Narnatumab Demcizumab Imgatuzumab Istiratumab Carotuximab TOMARALIMAB (托拉利单抗 ) Spiro[5,7-etheno-1H,11H-cyclobut[i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-2(3H),1'(2'H)-naphthalen]-8(9H)-one, 6'-chloro-3',4',12,13,16,16a,17,18,18a,19-decahydro-16-methoxy-11,12-dimethyl-16-[[(9aR)-octahydro-2H-pyrido[1,2-a]pyrazin-2-yl]methyl]-, 10,10-dioxide, (1'S,11R,12S,14E,16R,1... 沙戈匹隆 塔拉妥单抗 乌巴妥单抗 L-Alaninamide, N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]carbonyl]oxy]methyl]phenyl]- OZURIFTAMAB 地宁妥珠单抗 Vobramitamab BOSEROLIMAB 化合物 Enzomenib 利托那韦EP杂质35 2-(1-环己基-4-哌啶基)-6-氟-2,3-二氢-3-氧代-1H-异吲哚-4-甲酰胺 Research Grade Evorpacept 2-133-Interleukin 2 [125-serine] (human), [65-[N6-[[2-[8-[4-[(2-hydroxyethyl)amino]-1,4-dioxobutyl]-8,9-dihydro-1H(or 3H)-dibenzo[b,f]-1,2,3-triazolo[4,5-d]azocin-1(or 3)-yl]ethoxy]carbonyl]lysine]] ether with α-hydro-ω-methoxypoly(oxy-1,2-ethanediyl) (ACI) Research Grade Nezastomig 4-(Iodo-131I)-L-phenylalanine IBRITUMOMAB TIUXETAN Revumenib柠檬酸盐 1-Pyrrolidinecarboxamide, 3,3-dimethyl-N-[6-methyl-5-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-oxo-, hydrochloride, hydrate (1:1:1) Cintredekin besudotox Benzamide, N-ethyl-5-fluoro-2-[[5-[2-[(1R)-4-[(2-methoxyethyl)methylamino]-1-(1-methylethyl)butyl]-2,6-diazaspiro[3.4]oct-6-yl]-1,2,4-triazin-6-yl]oxy]-N-(1-methylethyl)-, compd. with benzenesulfonate (1:2) 溴匹立明 阿柏西普 N-(4-甲氧基苯基)-N,2-二甲基-4-喹唑啉胺盐酸盐 瑞格非尼(水合物) TG-101348 5-氨基乙酰丙酸 NMDA 脱氢雌马酚 亚美克松 MOCETINOSTAT HYDROBROMIDE 无结构图 恩西地平 TALAZOPARIB TOSYLATE Entolimod